Concepedia

Sara Petta

SP

Statistics

Publications

5

Citations

227

H-Index

5

Active since

2009

Affiliations

University of Bologna(Current)

University of Siena

Istituto di Ematologia di Bologna

Istituto Oncologico Romagnolo

Sara Petta is an author at University of Bologna specializing in medicine, oncology, and bcr-abl1 fusion gene.

Publications per year

2009–2010

5

Publications

5

Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein–protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis

Valentina Corradi, Manuela Mancini, Fabrizio Manetti et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 78 citations

, , +15

A New Nonpeptidic Inhibitor of 14-3-3 Induces Apoptotic Cell Death in Chronic Myeloid Leukemia Sensitive or Resistant to Imatinib

Manuela Mancini, Valentina Corradi, Sara Petta et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 62 citations

, , +13

Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells

Manuela Mancini, Sara Petta, Ilaria Iacobucci et al. · Cellular Signalling · 2010 · 34 citations

, , +12

mTOR inhibitor RAD001 (Everolimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-ABL protein

Manuela Mancini, Valentina Corradi, Sara Petta et al. · Leukemia Research · 2009 · 28 citations

, , +13

RAD 001 (everolimus) prevents mTOR and Akt late re‐activation in response to imatinib in chronic myeloid leukemia

Manuela Mancini, Sara Petta, Giovanni Martinelli et al. · Journal of Cellular Biochemistry · 2009 · 25 citations

, , +15

1–5 of 5